High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease
Status:
Withdrawn
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess survival of patients with advanced cardiac AL amyloidosis
treated with high cut-off hemodialysis (HCO-HD) combined with chemotherapy.